×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Oncostream member and receive full access to its content!
You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.
Registration Login
Registration Login
Modérateurs : Dr Caroline Bouche, Dr Jean- Marc Classe & Dr Jean-Sébastien Frénel
Intervenants :
Dr Jean-Sébastien Frénel,
Pr Emmanuel Barranger, Centre Antoine Lacassagne, Nice
Pr Roman Rouzier, Institut Curie, Paris
Dr Jean-Marc Classe, Institut de cancerologie de l'ouest, Nantes
|
Cas n°1 : Cancer du sein Triple négatif apparemment accessible à une chirurgie première…. Est-ce toujours une bonne idée ? Dr Jean-Sébastien Frénel |
|
|
Cas n°2 : Cancer du sein T1 RH+/HER2- : quelle indication de chirurgie axillaire en fonction du statut N clinique ? Pr Emmanuel Barranger |
|
|
Cas n°3 : Cancer du sein RH+/ HER2neg de 4 cm : comment pondérer l’indication de traitement systémique ? Place d’une signature génomique. Pr Roman Rouzier |
|
|
Cas n°4 : Patiente initialement N0, traitée par CNA : quelle chirurgie axillaire après la CNA ? Dr Jean-Marc Classe |
.gif)
Shooting date : 2024-05-22
Last update : 2024-06-05
Last update : 2024-06-05
Suggestions
Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, April 20th 2022 from 06am to 07:30am (GMT-10)
San Francisco : Wednesday, April 20th 2022 from 09am to 10:30am (GMT-7)
New York : Wednesday, April 20th 2022 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT-3)
Reykjavik : Wednesday, April 20th 2022 from 04pm to 05:30pm (GMT)
London / Dublin : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+4)
Bangkok : Wednesday, April 20th 2022 from 11pm to 12:30am (GMT+7)
Shanghai : Thursday, April 21st 2022 from 12am to 01:30am (GMT+8)
Tokyo : Thursday, April 21st 2022 from 01am to 02:30am (GMT+9)
Sydney : Thursday, April 21st 2022 from 03am to 04:30am (GMT+11)
Wellington : Thursday, April 21st 2022 from 05am to 06:30am (GMT+13)
San Francisco : Wednesday, April 20th 2022 from 09am to 10:30am (GMT-7)
New York : Wednesday, April 20th 2022 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT-3)
Reykjavik : Wednesday, April 20th 2022 from 04pm to 05:30pm (GMT)
London / Dublin : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+4)
Bangkok : Wednesday, April 20th 2022 from 11pm to 12:30am (GMT+7)
Shanghai : Thursday, April 21st 2022 from 12am to 01:30am (GMT+8)
Tokyo : Thursday, April 21st 2022 from 01am to 02:30am (GMT+9)
Sydney : Thursday, April 21st 2022 from 03am to 04:30am (GMT+11)
Wellington : Thursday, April 21st 2022 from 05am to 06:30am (GMT+13)
Cancer du sein
Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie
Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Thursday, February 1st 2024 from 06am to 07:30am (GMT-10)
San Francisco : Thursday, February 1st 2024 from 08am to 09:30am (GMT-8)
New York : Thursday, February 1st 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Thursday, February 1st 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Thursday, February 1st 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, February 1st 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Thursday, February 1st 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Friday, February 2nd 2024 from 12am to 01:30am (GMT+8)
Tokyo : Friday, February 2nd 2024 from 01am to 02:30am (GMT+9)
Sydney : Friday, February 2nd 2024 from 02am to 03:30am (GMT+10)
Wellington : Friday, February 2nd 2024 from 04am to 05:30am (GMT+12)
San Francisco : Thursday, February 1st 2024 from 08am to 09:30am (GMT-8)
New York : Thursday, February 1st 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Thursday, February 1st 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Thursday, February 1st 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, February 1st 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Thursday, February 1st 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Friday, February 2nd 2024 from 12am to 01:30am (GMT+8)
Tokyo : Friday, February 2nd 2024 from 01am to 02:30am (GMT+9)
Sydney : Friday, February 2nd 2024 from 02am to 03:30am (GMT+10)
Wellington : Friday, February 2nd 2024 from 04am to 05:30am (GMT+12)
Prise en charge du cancer du sein métastatique HER2-faible
Cycle d'enseignement - Le cancer du sein
Share
Monday, February 5th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, February 5th 2024 from 06am to 07:30am (GMT-10)
San Francisco : Monday, February 5th 2024 from 08am to 09:30am (GMT-8)
New York : Monday, February 5th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Monday, February 5th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Monday, February 5th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Monday, February 5th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, February 5th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Monday, February 5th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Monday, February 5th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Tuesday, February 6th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Tuesday, February 6th 2024 from 01am to 02:30am (GMT+9)
Sydney : Tuesday, February 6th 2024 from 02am to 03:30am (GMT+10)
Wellington : Tuesday, February 6th 2024 from 04am to 05:30am (GMT+12)
San Francisco : Monday, February 5th 2024 from 08am to 09:30am (GMT-8)
New York : Monday, February 5th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Monday, February 5th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Monday, February 5th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Monday, February 5th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, February 5th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Monday, February 5th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Monday, February 5th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Tuesday, February 6th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Tuesday, February 6th 2024 from 01am to 02:30am (GMT+9)
Sydney : Tuesday, February 6th 2024 from 02am to 03:30am (GMT+10)
Wellington : Tuesday, February 6th 2024 from 04am to 05:30am (GMT+12)
Orientation de la stratégie thérapeutique dans le cancer du sein métastatique RH+/HER2-
Share
Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Thursday, January 18th 2024 from 06am to 07:30am (GMT-10)
San Francisco : Thursday, January 18th 2024 from 08am to 09:30am (GMT-8)
New York : Thursday, January 18th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Thursday, January 18th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Thursday, January 18th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, January 18th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Thursday, January 18th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Friday, January 19th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Friday, January 19th 2024 from 01am to 02:30am (GMT+9)
Sydney : Friday, January 19th 2024 from 02am to 03:30am (GMT+10)
Wellington : Friday, January 19th 2024 from 04am to 05:30am (GMT+12)
San Francisco : Thursday, January 18th 2024 from 08am to 09:30am (GMT-8)
New York : Thursday, January 18th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Thursday, January 18th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Thursday, January 18th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, January 18th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Thursday, January 18th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Friday, January 19th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Friday, January 19th 2024 from 01am to 02:30am (GMT+9)
Sydney : Friday, January 19th 2024 from 02am to 03:30am (GMT+10)
Wellington : Friday, January 19th 2024 from 04am to 05:30am (GMT+12)
Cancer du sein triple négatif métastatique
Cycle d'enseignement - Le cancer du sein
Share